Results 271 to 277 of about 11,127 (277)

The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma

Allergy: European Journal of Allergy and Clinical Immunology, 2019
Frank C Albers, Kenneth R Chapman, Robert G Price   +2 more
exaly  

Mepolizumab—a novel option for the treatment of hypereosinophilic syndrome in childhood

Pediatric Allergy and Immunology, 2018
Carsten Schwarz, Carsten Schwarz
exaly  

Mepolizumab use

Annals of Allergy, Asthma & Immunology, 2018
Mariel R. Benjamin, Bruce S. Bochner, Anju T. Peters   +2 more
openaire   +3 more sources

Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma

New England Journal of Medicine, 2014
Ian D Pavord, Guy G Brusselle, Mohsen Sadatsafavi   +2 more
exaly  

Treatment response with mepolizumab in severe eosinophilic asthma patients with previous omalizumab treatment

Allergy: European Journal of Allergy and Clinical Immunology, 2016
exaly  

Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease

New England Journal of Medicine, 2017
Ian D Pavord, Gerard J Criner, Huib A M Kerstjens   +2 more
exaly  

Mepolizumab for episodic angioedema with eosinophilia

Journal of Allergy and Clinical Immunology
openaire   +2 more sources